Neoadjuvant Vindesine, Etoposide, and Cisplatin for Locally Advanced Non-Small Cell Lung Cancer
- 1 July 1989
- Vol. 96 (1) , 110-113
- https://doi.org/10.1378/chest.96.1.110
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.Journal of Clinical Oncology, 1988
- Staging of Lung CancerThe Annals of Thoracic Surgery, 1987
- Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology groupCancer, 1987
- Simultaneous Cisplatin Fluorouracil Infusion and Radiation Followed by Surgical Resection in Regionally Localized Stage III, Non–Small Cell Lung CancerThe Annals of Thoracic Surgery, 1987
- Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary reportCancer, 1986
- Camp chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975–1981) with 160 patientsCancer, 1985
- Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatinCancer, 1985
- Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapyCancer, 1982